|
2024
|
Invention
|
Diaminopyrimidines as p2x3 and p2x2/3 antagonists.
Compounds and methods for treating diseases m... |
|
|
Invention
|
Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respirato... |
|
2021
|
Invention
|
Tetralin and indane derivatives and uses thereof.
The application discloses pharmaceutical compo... |
|
2020
|
Invention
|
Method for improving pharmacokinetics. The object of the present invention is to inhibit oxidativ... |
|
2018
|
Invention
|
Method for improving pharmacokinetics.
The object of the present invention is to inhibit oxidati... |
|
|
Invention
|
Tetralin and indane derivatives and uses thereof.
The applicaton discloses pharmaceutical compou... |
|
|
Invention
|
Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators.
Compounds of the formula I or II:
Co... |
|
2017
|
Invention
|
2/3 antagonists. 2/3 receptor with compounds of the formula I:
b are as defined herein.
|
|
|
Invention
|
2/3 antagonists. 2/3 receptors treating a patient with a compound of formula I
2/3 receptor anta... |
|
2016
|
Invention
|
2/3 antagonists. Compounds of the formula I:
2/3 receptor antagonists and methods of making the ... |
|
|
Invention
|
Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists.
Compounds of the formula I:
... |
|
|
Invention
|
Substituted pyridines as p2x3 and p2x2/3 antagonists.
Methods of treating diseases associated wi... |
|
|
Invention
|
Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists.
Compounds of the f... |
|
|
Invention
|
Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonists. Compounds of the form... |
|
2015
|
Invention
|
Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists.
Compounds of the formula I:
... |
|
2014
|
Invention
|
Tetralin and indane derivatives and uses thereof. Compounds of the formula I:
2 are as defined h... |
|
|
Invention
|
2/3 antagonists. Compounds of the formula I:
2/3 receptor antagonist and methods of making the ... |
|
|
Invention
|
2/3 antagonists. 2/3 receptor antagonist, the methods comprising administering to a subject in ne... |
|
|
Invention
|
2/3 antagonists. Compounds of the formula I:
2/3 receptor antagonists and methods of making the... |
|
|
Invention
|
Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators. Compounds of the formula I or II:
2 ar... |
|
2013
|
Invention
|
Process for synthesis of phenoxy diaminopyrimidine derivatives. A method for preparing a compound... |
|
|
Invention
|
Liquid pharmaceutical formulations of palonosetron.
The present invention relates to shelf-stabl... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. This application discloses 5-phenyl-1H-pyridin-2-one and ... |
|
|
Invention
|
Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonists.
Compounds of the for... |
|
|
Invention
|
Isoxazolo-pyridine derivatives. The present invention is concerned with isoxazole-pyridine deriva... |
|
|
Invention
|
Triazole-substituted arylamides as p2x3 and p2x2/3 modulators.
Compounds of the formula I:
Com... |
|
|
Invention
|
1,2-pyridazines, 1,6-pyridazines and pyrimidines. This invention relates to novel 1,2-pyridazines... |
|
|
Invention
|
Pyrazole-substituted arylamides as p2x3 and p2x2/3 antagonists.
Compounds of the formula I:
Co... |
|
2012
|
Invention
|
Method for predicting clinical benefit in the treatment of neurodevelopmental, neurological or ne... |
|
2011
|
Invention
|
Heterocyclic antiviral compounds. 3 and X are as defined herein are Hepatitis C virus NS5b polyme... |
